Echosens

Empowering medical professionals to assess, diagnoseand manage chronic liver diseases, everywhere,for simpler, faster and better patient care and liver health. In 2003, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the unique device using patented and validated VCTE™ for liver stiffness assessment, and CAP™ for steatosis quantification.FibroScan® device is recognized worldwide as the reference for non invasive liver diagnosis with more than 2,400 medical publications and 40 guidelines recommendations. We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH. As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.